UAS
IBIO icon

United Asset Strategies’s iBio IBIO Stock Holding History

United Asset Strategies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2
Closed -$2K – 199
2018
Q1 		$2K Hold
2
– – ﹤0.01% 195
2017
Q4 		$2K Hold
2
– – ﹤0.01% 190
2017
Q3 		$3K Hold
2
– – ﹤0.01% 121
2017
Q2 		$4K Hold
2
– – ﹤0.01% 150
2017
Q1 		$4K Hold
2
– – ﹤0.01% 146
2016
Q4 		$4K Hold
2
– – ﹤0.01% 147
2016
Q3 		$6K Hold
2
– – ﹤0.01% 137
2016
Q2 		$7K Hold
2
– – ﹤0.01% 139
2016
Q1 		$6K Hold
2
– – ﹤0.01% 126
2015
Q4 		$6K Hold
2
– – ﹤0.01% 137
2015
Q3 		$7K Hold
2
– – ﹤0.01% 126
2015
Q2 		$10K Buy
+2
New +$9.3K ﹤0.01% 128
2015
Q1 		– Sell
-2
Closed -$7K – 119
2014
Q4 		$7K Buy
+2
New +$10.7K ﹤0.01% 128

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

United Asset Strategies's IBIO Position: Q2 2018 in Review

United Asset Strategies sold out of iBio (IBIO) in Q2 2018, closing a stake of 2 shares — an estimated $2K sold.

United Asset Strategies first reported a position in IBIO in Q4 2014 and held it in 13 quarters. The position peaked at $10K in Q2 2015. 10 funds tracked by Wall St. Rank hold IBIO as of Q2 2018.

  • United Asset Strategies reported no remaining iBio position as of Q2 2018 after selling out during the quarter.
  • United Asset Strategies sold 2 iBio shares in Q2 2018, an estimated $2K.
  • United Asset Strategies first reported a position in iBio in Q4 2014 and held it in 13 quarters.
  • United Asset Strategies's iBio position peaked at $10K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held iBio as of Q2 2018.

Based on United Asset Strategies's 13F filing for Q2 2018, filed 7 Aug 2018.